151. miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6
- Author
-
Sihai Zhao, Ning Wang, Huan Zhong, Bin Yu, Liangjun Tao, Xiaonong Chen, Rongjiang Wang, Jianguo Gao, and Ying Yu
- Subjects
0301 basic medicine ,Cancer Research ,Cell ,Biology ,Metastasis ,miR-135b ,03 medical and health sciences ,Prostate cancer ,0302 clinical medicine ,Downregulation and upregulation ,microRNA ,medicine ,metastasis ,STAT6 ,Oncogene ,Articles ,Cell cycle ,prostate cancer ,medicine.disease ,Molecular medicine ,Molecular biology ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,Cancer research - Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that participate in several cellular functions and tumour progression. A previous microarray study demonstrated that miR-135b is downregulated in prostate cancer (PCa) cells, but the role and molecular mechanism of miR-135b in the regulation of tumour metastasis remain to be elucidated. In the present study, significant downregulation of miR-135b in PCa tissues, compared with noncancerous tissues, was detected by reverse transcription-quantitative polymerase chain reaction. Furthermore, the expression of miR-135b was demonstrated to be associated with the pathological stage and the levels of total and free prostate-specific antigen (PSA) in PCa cells. In addition, signal transducer and activator of transcription 6 (STAT6) was identified as a target of miR-135b in PCa cells by luciferase activity and western blot assays. The upregulation of miR-135b in PCa cells led to reduced expression of STAT6 in the cytoplasm and nucleus of these cells, while the overexpression of miR-135b and knockdown of STAT6 were able to inhibit the migration and invasion abilities of PCa cells in vitro. Therefore, the results of the present study indicate that miR-135b suppresses tumour metastasis by targeting STAT6.
- Published
- 2015